Glooko, Inc., a Palo Alto, CA-based global integrated digital health company connecting patients, providers, biopharma and medical device partners, raised $100m in Series F financing.
The round was led by Georgian, with participation from Health Catalyst Capital, Canaan and other investors and business partners.
The company intends to use the funds to accelerate global product expansion of its digital healthcare platform and life sciences work, which empowers people with diabetes to manage their condition and strengthen the engagement with and care from their healthcare team.
Led by newly appointed CEO Mike Alvarez, Chief Executive Officer, Glooko improves health outcomes of people with chronic conditions through its personalized, intelligent, connected care and life sciences platform. More than 4.4 million people around the world with diabetes have used the Glooko platform.
Mr. Alvarez brings more than two decades of leadership experience with multinational companies in medical devices and biotechnology. Most recently, Mr. Alvarez served as Chief Executive Officer of Qardio, a leader in remote patient monitoring and technology solutions for chronic disease management. Prior to Qardio, Mr. Alvarez held leadership positions at Medtronic, St. Jude Medical (acquired by Abbott), and Sanofi.
FinSMEs
10/10/2024